Top Cited Articles
(69 articles with 737 citations as of July 2024)

• Wireless accelerometer configuration for monitoring Parkinson’s disease hand tremor, Advances in Parkinson's Disease, Vol.2 No.2, 2013
• Robert LeMoyne, Timothy Mastroianni, Warren Grundfest
• Citations: 65 (Details)

• The effects of a supervised Pilates training program on balance in Parkinson’s disease, Advances in Parkinson's Disease, Vol.2 No.2, 2013
• Liam Johnson, David Putrino, Ian James, Julian Rodrigues, Rick Stell, Gary Thickbroom, Frank L. Mastaglia
• Citations: 62 (Details)

• Biological sources of L-DOPA: An alternative approach, Advances in Parkinson's Disease, Vol.2 No.3, 2013
• Sushama A. Patil, Onkar A. Apine, Shripad N. Surwase, Jyoti P. Jadhav
• Citations: 52 (Details)

• Curcumin protects against rotenone-induced neurotoxicity in cell and drosophila models of Parkinson’s disease, Advances in Parkinson's Disease, Vol.2 No.1, 2013
• Zhaohui Liu, Tianxia Li, Dejun Yang, Wanli W. Smith
• Citations: 52 (Details)

• Virtual games and quality of life in Parkinson’s disease: A randomised controlled trial, Advances in Parkinson's Disease, Vol.2 No.4, 2013
• Glicia Pedreira, Antonio Prazeres, Danilo Cruz, Irênio Gomes, Larissa Monteiro, Ailton Melo
• Citations: 36 (Details)

• Wearable and wireless accelerometer systems for monitoring Parkinson’s disease patients—A perspective review, Advances in Parkinson's Disease, Vol.2 No.4, 2013
• Robert LeMoyne
• Citations: 36 (Details)

• Pragmatic language production deficits in Parkinson’s disease, Advances in Parkinson's Disease, Vol.2 No.1, 2013
• Thomas Holtgraves, Kelly Fogle, Lindsay Marsh
• Citations: 34 (Details)

• Aquatic physical therapy for Parkinson’s disease, Advances in Parkinson's Disease, Vol.2 No.4, 2013
• Talita Gianello Gnoato Zotz, Eliani Arruda Souza, Vera Lúcia Israel, Ana Paula Cunha Loureiro
• Citations: 26 (Details)

• Implementation of a Smartphone as a Wearable and Wireless Accelerometer and Gyroscope Platform for Ascertaining Deep Brain Stimulation Treatment Efficacy of Parkinson’s Disease through Machine Learning Classification, Advances in Parkinson's Disease, Vol.7 No.2, 2018
• Robert LeMoyne, Timothy Mastroianni, Cyrus McCandless, Christopher Currivan, Donald Whiting, Nestor Tomycz
• Citations: 26 (Details)

• Comparison of the Analgesic Activity of Antiparkinsonian Aminoadamantane Derivatives Amantadine and Hemantane, Advances in Parkinson's Disease, Vol.5 No.3, 2016
• Elena Ivanova, Inga Kapitsa, Elena Valdman, Tatyana Voronina
• Citations: 22 (Details)

• Tai Chi in Parkinson’s Disease: A Preliminary Randomized, Controlled, and Rater-Blinded Study, Advances in Parkinson's Disease, Vol.4 No.1, 2015
• Roger Kurlan, Roye Evans, Sandra Wrigley, Shannon McPartland, Rami Bustami, Ann Cotter
• Citations: 22 (Details)

• The Development of Treatment for Parkinson’s Disease, Advances in Parkinson's Disease, Vol.4 No.3, 2015
• Harishankar Prasad Yadav, Yun Li
• Citations: 21 (Details)

• Racial Disparities in Parkinson Disease: A Systematic Review of the Literature, Advances in Parkinson's Disease, Vol.5 No.4, 2016
• Chantale O. Branson, Andrew Ferree, Anna D. Hohler, Marie-Helene Saint-Hilaire
• Citations: 21 (Details)

• The International Classification of Functioning, Disability and Health as Applied to Parkinson’s Disease: A Literature Review, Advances in Parkinson's Disease, Vol.5 No.2, 2016
• Audrin Said Vojciechowski, Talita Gianello Gnoato Zotz, Ana Paula Cunha Loureiro, Vera Lúcia Israel
• Citations: 17 (Details)

• Properties of the Apathy Scale (AS) for use on Parkinson’s patients, Advances in Parkinson's Disease, Vol.2 No.2, 2013
• Marcos Serrano-Dueñas, Pablo Martínez-Martín, Tamara Merchán, Rosaura Bravo, Maite Serrano
• Citations: 14 (Details)

• Effect of Abnormal Posture on Quality of Life in Patients with Parkinson’s Disease, Advances in Parkinson's Disease, Vol.5 No.2, 2016
• Kyohei Mikami, Makoto Shiraishi, Tsutomu Kamo
• Citations: 13 (Details)

• The Effects of Exercise on People with Parkinson’s Disease—Review, Advances in Parkinson's Disease, Vol.6 No.1, 2017
• Iva Musulin
• Citations: 12 (Details)

• Should gait speed be included in the clinical evaluation of Parkinson’s disease?, Advances in Parkinson's Disease, Vol.1 No.1, 2012
• Joe Nocera, Chris Hass
• Citations: 12 (Details)

• Potential of a planarian model to study certain aspects of anti-Parkinsonism drugs, Advances in Parkinson's Disease, Vol.2 No.3, 2013
• Robert B. Raffa, Jeff Danah, Christopher S. Tallarida, Carrie Zimmerman, Grace Gill, Steven J. Baron, Scott M. Rawls
• Citations: 11 (Details)

• Evaluation of Clinical Utility of the Personal KinetiGraph^® in the Management of Parkinson Disease, Advances in Parkinson's Disease, Vol.8 No.3, 2019
• Fatta B. Nahab, Hamad Abu-Hussain, Lissette Moreno
• Citations: 11 (Details)

• Effectiveness of Istradefylline for Fatigue and Quality of Life in Parkinson’s Disease Patients’ and of Their Caregivers’, Advances in Parkinson's Disease, Vol.5 No.2, 2016
• Kazuo Abe, Masashi Fujita, Hiroo Yoshikawa
• Citations: 11 (Details)

• Aquatic Physiotherapy and Parkinson’s Disease: Effects on Functional Motor Skills, Advances in Parkinson's Disease, Vol.9 No.1, 2020
• Bruna Yamaguchi, Manoela de Paula Ferreira, Vera Lúcia Israel
• Citations: 9 (Details)

• The Application of Palliative Care Principles in Advanced Parkinson’s Disease, Advances in Parkinson's Disease, Vol.5 No.4, 2016
• Sunjay Sethi, Anna DePold Hohler
• Citations: 8 (Details)

• Parkinson’s Disease Treatment as Seen from a Mechanical Point of View, Advances in Parkinson's Disease, Vol.5 No.4, 2016
• Sarah Gebai, Mohamad Hammoud
• Citations: 8 (Details)

• The Cardiovascular and Cerebrovascular Effects on Cognition in Persons with Parkinson’s Disease: A Systematic Review of the Literature, Advances in Parkinson's Disease, Vol.4 No.2, 2015
• Adrianna Carey, Rebecca Julian, Katlyn Kristeller, Peter Leonard, Sara Palmer, Laura Krisa
• Citations: 7 (Details)

• A prescription for physical therapy and exercise in Parkinson’s disease, Advances in Parkinson's Disease, Vol.2 No.4, 2013
• Marie Saint-Hilaire, Theresa Ellis
• Citations: 6 (Details)

• Planning a Patient-Centered Parkinson’s Disease Support Program: Insights from Narrative Medicine, Advances in Parkinson's Disease, Vol.3 No.4, 2014
• Nancy Gross, Melissa Nicolas, Susan Neigher, Shannon McPartland, Melvyn Heyes, Sandra Wrigley, Roger Kurlan
• Citations: 6 (Details)

• Pseudoparkinsonism: A review of a common nonparkinsonian hypokinetic movement disorder, Advances in Parkinson's Disease, Vol.2 No.4, 2013
• Roger Kurlan, Marcie L. Rabin
• Citations: 6 (Details)

• Is Levodopa Pharmacokinetics in Patients with Parkinson’s Disease Depending on Gastric Emptying?, Advances in Parkinson's Disease, Vol.6 No.1, 2017
• Maria Nord, Anita Kullman, Ulf Hannestad, Nil Dizdar
• Citations: 6 (Details)

• A Brief Clinical Assessment of Cognitive Deficit with Impaired Daily Living Functioning in Parkinson’s Patients with and without Dementia, Advances in Parkinson's Disease, Vol.5 No.2, 2016
• Sadaf Naeem, Rahila Najam, Nausheen Alam, Syed Waseem Akhter
• Citations: 6 (Details)

• Frequency of Low Vitamin D3 Levels in Subjects with Parkinson’s Disease. A Study Conducted at PMCH, a Tertiary Care Hospital, Nawabshah, Advances in Parkinson's Disease, Vol.7 No.1, 2018
• Anwar Ali Jamali, Ghulam Mustafa Jamali, Bhojo Mal Tanwani, Niaz Hussain Jamali, Moti Ram Bhatia
• Citations: 6 (Details)

• Distinction of an Assortment of Deep Brain Stimulation Parameter Configurations for Treating Parkinson’s Disease Using Machine Learning with Quantification of Tremor Response through a Conformal Wearable and Wireless Inertial Sensor, Advances in Parkinson's Disease, Vol.9 No.3, 2020
• Robert LeMoyne, Timothy Mastroianni, Donald Whiting, Nestor Tomycz
• Citations: 6 (Details)

• Preliminary Network Centric Therapy for Machine Learning Classification of Deep Brain Stimulation Status for the Treatment of Parkinson’s Disease with a Conformal Wearable and Wireless Inertial Sensor, Advances in Parkinson's Disease, Vol.8 No.4, 2019
• Robert LeMoyne, Timothy Mastroianni, Donald Whiting, Nestor Tomycz
• Citations: 6 (Details)

• Efficacy of rehabilitation program in addition to pharmacological treatment during 8 months in Parkinson patients, Advances in Parkinson's Disease, Vol.1 No.2, 2012
• Jesús Seco Calvo, Inés Gago Fernández, Juan Azael Herrero Alonso, Javier González Gallego, Nuria Garatachea Vallejo
• Citations: 5 (Details)

• Preliminary evidence of discourse improvement with dopaminergic medication, Advances in Parkinson's Disease, Vol.2 No.2, 2013
• Janelle Sanchez, Kristie A. Spencer
• Citations: 5 (Details)

• Low Frequency of Leisure-Time Activities Correlates with Cognitive Decline and Apathy in Patients with Parkinson’s Disease, Advances in Parkinson's Disease, Vol.3 No.3, 2014
• Kayoko Miura, Shutaro Takashima, Mie Matsui, Kortaro Tanaka
• Citations: 5 (Details)

• Medical Food to Stop the Progression of Parkinson’s Disease, Advances in Parkinson's Disease, Vol.3 No.2, 2014
• Don McCammon
• Citations: 4 (Details)

• Lack of Association between Impulse Control Disorders and REM Sleep Behavior Disorder in Patients with Parkinson’s Disease, Advances in Parkinson's Disease, Vol.5 No.4, 2016
• Lisette Bazán-Rodríguez, Mayela Rodríguez-Violante, Amin Cervantes-Arriaga, Guillermo Parra-López, Diego Cruz-Fino, Francisco Pascasio-Astudillo, Vanessa Alatriste-Booth
• Citations: 4 (Details)

• Levodopa Pharmacokinetics in Brain after Both Oral and Intravenous Levodopa in One Patient with Advanced Parkinson’s Disease, Advances in Parkinson's Disease, Vol.6 No.2, 2017
• Maria Nord, Peter Zsigmond, Anita Kullman, Nil Dizdar
• Citations: 4 (Details)

• Temporal Aspects of Global Coherence during Discourse Production in Early Stage Parkinson’s Disease, Advances in Parkinson's Disease, Vol.5 No.3, 2016
• Charles Ellis, Xiangming Fang, Patrick Briley
• Citations: 3 (Details)

• Clinical Experience with Generic Rasagiline (Ralago^®) in Patients with Parkinson’s Disease: An Open-Label, Multicenter, Observational Study, Advances in Parkinson's Disease, Vol.8 No.2, 2019
• Dávid Pintér, Júlia Lajtos, József Janszky, Norbert Kovács
• Citations: 3 (Details)

• Parkinson Kinetic Graph: Are Motor Fluctuations in Parkinson Disease Related with Disease Duration?, Advances in Parkinson's Disease, Vol.7 No.1, 2018
• Esther Berghuis, Barbera Van Harten, Mirjam Van Kesteren-Biegstraaten, Wijnand Rutgers, Nicolaas Verwey
• Citations: 3 (Details)

• Differences between Istradefylline Responders and Non-Responders in Parkinson’s Disease, Advances in Parkinson's Disease, Vol.6 No.2, 2017
• Asako Yoritaka, Nobutaka Hattori
• Citations: 3 (Details)

• Quantitative EEG Changes in Patients with Parkinson’s Disease during Therapy with Rasagiline, Advances in Parkinson's Disease, Vol.3 No.3, 2014
• Wilfried Dimpfel, Christian Oehlwein, Josef Anton Hoffmann, Thomas Müller
• Citations: 3 (Details)

• Parkinson’s disease: Is there a light at the end of a tunnel?, Advances in Parkinson's Disease, Vol.2 No.4, 2013
• Andrei Surguchov
• Citations: 3 (Details)

• Inhibition of foxo and minibrain in Dopaminergic Neurons Can Model Aspects of Parkinson Disease in Drosophila melanogaster, Advances in Parkinson's Disease, Vol.5 No.1, 2016
• Mahin S. Chavoshi, Brian E. Staveley
• Citations: 3 (Details)

• Pink1 and parkin demonstrate multifaceted roles when co-expressed with Foxo, Advances in Parkinson's Disease, Vol.2 No.1, 2013
• Amy M. Todd, Brian E. Staveley
• Citations: 3 (Details)

• The activity of antiparkinsonian drug hemantane in models of peripheral inflammation and lipopolysaccharide-induced neuroinflammation, Advances in Parkinson's Disease, Vol.2 No.1, 2013
• Elena Ivanova, Inga Kapitsa, Elena Valdman, Tatyana Voronina
• Citations: 2 (Details)

• Factors affecting early decline of executive function after subthalamic nucleus stimulation in Parkinson’s disease, Advances in Parkinson's Disease, Vol.2 No.3, 2013
• Atsushi Umemura, Yuichi Oka, Rika Tsuboi, Sonoko Fujii, Yoko Shimizu, Kenji Okita, Noriyuki Matsukawa, Kazuo Yamada
• Citations: 2 (Details)

• LDN-73794 Attenuated LRRK2-Induced Degeneration in a Drosophila Parkinson’s Disease Model, Advances in Parkinson's Disease, Vol.4 No.3, 2015
• Dejun Yang, Sharmila Das, Loujing Song, Tianxia Li, Jianqun Yan, Wanli W. Smith
• Citations: 2 (Details)

• Five-Year Outcomes of Bilateral Subthalamic Nucleus Stimulation in Japanese Patients with Parkinson’s Disease, Advances in Parkinson's Disease, Vol.4 No.2, 2015
• Atsushi Umemura, Miwako Miyata, Yuichi Oka, Kenji Okita, Genko Oyama, Yasushi Shimo, Nobutaka Hattori
• Citations: 2 (Details)

• Frequency and Associated Factors of Autonomic Dysfunction in Patients with Parkinson’s Disease in Khartoum State, Advances in Parkinson's Disease, Vol.8 No.4, 2019
• Abdel Mumin Sidahmed, Husam A. M. Ali
• Citations: 2 (Details)

• Resistance Training in Parkinson’s Disease: A Longitudinal Study, Advances in Parkinson's Disease, Vol.6 No.2, 2017
• Luca Beratto, Federico Abate Daga, Ruben Allois, Massimiliano Gollin
• Citations: 2 (Details)

• Levodopa/Carbidopa Intestinal Gel for Treatment of Advanced Parkinson’s Disease: An Update on the Effects of Cognitive Functions, Advances in Parkinson's Disease, Vol.6 No.1, 2017
• Pamela Latino, Stefania Tagliente, Clelia Pellicano, Morena Giovannelli, Francesco E. Pontieri
• Citations: 2 (Details)

• Sleep Disturbance in Parkinson’s Disease Varies with Age of Onset and Family History, Advances in Parkinson's Disease, Vol.5 No.4, 2016
• Divya Madhusudhan, Daniella Sisniega, Andrew Ferree, Janice Weinberg, Marie Saint-Hilaire, Samuel Ellias, Anna DePold Hohler
• Citations: 2 (Details)

• The Tower of Hanoi for Evaluating Dysexecutive Syndrome in Patients with Parkinson’s: Standardization Values, Advances in Parkinson's Disease, Vol.6 No.3, 2017
• Marcos Serrano-Dueñas, Belén Calero, Maite Serrano
• Citations: 1 (Details)

• Effect of Alteration of Glutathione Content on Cell Viability in α-Synuclein-Transfected SH-SY5Y Cells, Advances in Parkinson's Disease, Vol.6 No.3, 2017
• Ken-Ichi Tanaka, Kanako Sonoda, Masato Asanuma
• Citations: 1 (Details)

• Body Balance and Core Training in Parkinson’s Disease: A Longitudinal Crossover Study, Advances in Parkinson's Disease, Vol.6 No.4, 2017
• Allois Ruben, Beratto Luca, Ponzano Matteo, Di Leonardo Piergiacomo, Abate Daga Federico, Gollin Massimiliano
• Citations: 1 (Details)

• Contribution of Musculoskeletal Disorders to Chronic Lumbago in Parkinson’s Disease, Advances in Parkinson's Disease, Vol.5 No.3, 2016
• Makoto Shiraishi, Kensuke Shinohara, Masashi Akamatsu, Yasuhiro Hasegawa
• Citations: 1 (Details)

• Can We Use Consumer-Wearable Activity Tracker Fitbit in Parkinson Disease?, Advances in Parkinson's Disease, Vol.10 No.2, 2021
• Kazuo Abe
• Citations: 1 (Details)

• Effect of Varenicline on Detrusor Overactivity in Rat Model of Parkinson’s Disease Induced by Intranigral 6-Hydroxydopamine, Advances in Parkinson's Disease, Vol.11 No.1, 2022
• Zeynep Mine Altunay, Fatma Rüyal Tan, Nermin Bölükbaşı, Funda Fatma Bölükbaşı Hatip, Izzettin Hatip-Al-Khatib
• Citations: 1 (Details)

• On Heredity Factors of Parkinson’s Disease: A Parametric and Bayesian Analysis, Advances in Parkinson's Disease, Vol.7 No.3, 2018
• Abolfazl Saghafi, Chris P. Tsokos, Rebecca D. Wooten
• Citations: 1 (Details)

• A Report of 10 Cases of Parkinson’s Disease Cured by Xifengzhizhan Pills and Xifengzhizhan Capsules, Advances in Parkinson's Disease, Vol.8 No.2, 2019
• Weifan Wang
• Citations: 1 (Details)

• Pink1 Rescues Gal4-Induced Developmental Defects in the Drosophila Eye, Advances in Parkinson's Disease, Vol.4 No.3, 2015
• Amy M. Todd, Brian E. Staveley
• Citations: 1 (Details)

• Effects of Cholinesterase Inhibitors in Cognition on Parkinson’s Disease Dementia: A Systematic Review and Meta-Analysis, Advances in Parkinson's Disease, Vol.4 No.4, 2015
• Marina Martorelli, Larissa Monteiro, Ailton Melo
• Citations: 1 (Details)

• A Blueberry Extract Supplemented Diet Partially Restores α-Synuclein-Dependent Lifespan Loss and Developmental Defects in Drosophila, Advances in Parkinson's Disease, Vol.3 No.2, 2014
• David B. Lipsett, Brian E. Staveley
• Citations: 1 (Details)

• Association of adverse effects with monoamine oxidase type B inhibitor and catechol-o-methyl transferase inhibitor combination therapy in Parkinson’s disease patients, Advances in Parkinson's Disease, Vol.1 No.1, 2012
• Rui Zhang, Danielle C. Spengler, Marie-Helene Saint-Hilaire, Anna D. Hohler
• Citations: 1 (Details)

• Comparison of continuous versus pulsatile dopaminergic therapy in the erderly with Parkinson’s Disease, Advances in Parkinson's Disease, Vol.2 No.2, 2013
• Fulvio Lauretani, Gian Paolo Ceda, Augusto Scaglioni, Anna Nardelli
• Citations: 1 (Details)

• Analysis of known point mutations and SNPs in genes responsible for monogenic Parkinson’s disease in Russian patients, Advances in Parkinson's Disease, Vol.2 No.1, 2013
• Elena V. Filatova, Maria I. Shadrina, Ekaterina Y. Fedotova, Irina A. Ivanova-Smolenskaya, Sergei N. Illarioshkin, Svetlana A. Limborska, Petr A. Slominsky
• Citations: 1 (Details)